Purchase Order 75N93024P01150

Award Date 9/12/24
Potential Completion Date 12/11/24
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,081.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for a GENTLEMACS OCTO DISSOCIATOR WITH HEATERS scientific instrument and associated freight charges. The award does not utilize a set-aside designation. Miltenyi Biotec specializes in providing scientific instruments, bioreagents, and services to...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $8,347.50 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer. The contract is for the delivery of GentleMACTM Tumor Dissociator Kits, T-Cell Isolation Kits, and related columns. This purchase order is not associated with a set-aside program. Miltenyi Biotec is an experienced federal contractor, having provided specialized laboratory equipment,...
This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $5,406.00 firm fixed-price purchase order is for the delivery of a GentleMACS Dissociator instrument, a specialized tissue dissociation system used in biomedical research. The contract is not designated as a set-aside. Miltenyi Biotec is a global biotechnology company that provides scientific instruments,...
This is a $14,647 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID) for the delivery of a GentleMACS tissue homogenizer and associated supplies. The award is not associated with a set-aside. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the NIH, VA, and DoD to provide specialized laboratory equipment, reagents, and...
This is a $5,143.50 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for a GENTLEMACS DISSOCIATOR. The contract has no set-aside designation and was awarded on March 23, 2016 with a completion date of April 5, 2016. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc. for the delivery of a tissue dissociator, a specialized laboratory instrument used for processing biological samples. The $4,881 contract has a completion date of July 31, 2015 and was awarded on July 23, 2015 without any set-aside designation. Miltenyi Biotec is a global biotechnology company that provides instrumentation, reagents, and services to...
The U.S. government agency National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract worth $41,906.00 to Miltenyi Biotec, Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of an Automacs Pro Separator Starter Kit, a specialized scientific instrument used for cell separation and analysis. This award is not associated with a larger contract vehicle. The contract does not have a set-aside designation....
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $21,688.50 firm fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the delivery of a DISSOCIATOR WITH HEATERS. This contract has no set-aside designation. Miltenyi Biotec is a global biotechnology company that provides products and services supporting biomedical research, cell therapy development, and...
This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The award is for the purchase of 2 GENTLEMACS OCTO DISSOCIATORS WITH HEATING UNITS, totaling $48,320.00 on a firm fixed-price basis. The contract has an ultimate completion date of February 28, 2025. Miltenyi Biotec is a well-established federal...

This is a $31,160 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the delivery of a GentleMACS Octo Dissociator with heating units, which are specialized laboratory instruments used for tissue dissociation and cell isolation.

The award is not associated with a set-aside program. Miltenyi Biotec, a global biotechnology company, has extensive experience as a prime contractor for various government agencies, providing a range of products and services, including cell separation, analysis, and processing technologies. This purchase order supports the agency's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases.

Generated 9/13/24, 9:24 AM